PDA

View Full Version : DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan PDT in Brazil



NewsWhore
03-06-2008, 11:20 AM
DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA), received notice on March 5, 2008 that Stiefel Laboratories, Inc., DUSA's marketing partner for Latin America, has now received final pricing approval for ...

More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/13352890/)